Toward optimizing patient selection for EGFR antibody therapies in metastatic colorectal cancer: outcomes and resistance features in real-world data by M.J. Emmett, J.C.F. Quintanilha, R.P. Graf, G. Li, H. Tukachinsky, A.B. Schrock, S. Morley, V.A. Fisher, G.R. Oxnard, C.H. Lieu, P.A. Myer, S.J. Klempner

Get full text